Celgene's (CELG) future seems to be a big question mark

[NorFoster]

Celgene earnings details. A cut in the outlook, especially it's long-term targets, is not an encouraging one. Also, a decrease in pharma company's R&D expenses is not a good sign.

 

[Fenton Lum]

Celgene earnings details. A cut in the outlook, especially it's long-term targets, is not an encouraging one. Also, a decrease in pharma company's R&D expenses is not a good sign.

The pharma industry is in the business of societal wealth extraction, you don't need to invest in R&D for that.